Aquestive Therapeutics, Inc. (AQST) Net Income by Year
Aquestive Therapeutics, Inc. reported a net loss of $83.8M in fiscal year 2025. This represents a decrease of 89.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $78.2M net loss. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Aquestive Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AQST Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
AQST Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Aquestive Therapeutics, Inc. financials
Frequently Asked Questions
What was Aquestive Therapeutics, Inc.'s net income in fiscal year 2025?
Aquestive Therapeutics, Inc. reported a net loss of $83.8M in fiscal year 2025.
How fast is Aquestive Therapeutics, Inc.'s net income growing?
Aquestive Therapeutics, Inc. (AQST) net income fell by 89.8% year over year, from -$44.1M to -$83.8M in fiscal year 2025.
What is Aquestive Therapeutics, Inc.'s net income over the last twelve months?
Aquestive Therapeutics, Inc. (AQST) reported a $78.2M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Aquestive Therapeutics, Inc.'s net income changed over the years?
Across the 9 fiscal years this page covers, Aquestive Therapeutics, Inc. (AQST) net income went from -$8.9M in fiscal year 2017 to -$83.8M in fiscal year 2025.
What was Aquestive Therapeutics, Inc.'s net income in the most recent quarter?
Aquestive Therapeutics, Inc. (AQST) reported -$22.9M in net income in Q2 2026. This represents a decrease of 68.8% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Aquestive Therapeutics, Inc. (AQST) reported on that line in every period on record.